Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.64 USD
Change Today +0.002 / 0.31%
Volume 8.2K
SVON On Other Exchanges
As of 5:20 PM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Leslie J. Browne Ph.D.

Former President, Sevion Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 36 board members in 2 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Leslie J. Browne, Ph.D. has been President at Sevion Therapeutics, Inc. (alternate name Senesco Technologies Inc) since May 25, 2010. Dr. Browne serves as the President and Chief Executive Officer of Pharmacopeia Drug Discovery Inc. since July 2004. He served as the Chief Executive Officer at Sevion Therapeutics, Inc. since May 25, 2010. He served as the Chief Operating Officer of Iconix Pharmaceuticals Inc. and Chief Operating Officer of GeneTrace, a functional ...

Read Full Background

Corporate Headquarters*

721 Route 202/206
Bridgewater, New Jersey 08807

United States

Phone: 908-864-4444
Fax: --

Board Members Memberships*

Former Director
Chairman of the Board
Former Chief Executive Officer, President, Director, Member of Secondary Committee and Member of Strategic Planning Committee
Former Independent Director, Member of Nominating Committee and Member of Compensation Committee
Former President


PhD 1978
University of Michigan
BS 1972
University of Strathclyde

Other Affiliations*

Annual Compensation*

Total Annual Compensation$273,860

Stock Options*

Exercisable Options20,849
Total Number of Options41,578

Total Compensation*

Total Annual Cash Compensation$273,860
Total Short Term Compensation$273,860
Total Calculated Compensation$347,949
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SVON:US $0.64 USD +0.002


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEVION THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at